NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled